drugset / Trial / NCT01817283
Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders
RandomizedCrossoverDouble-blindTreatment
Summary
This study is a prospective, multicenter, randomized, placebo-controlled clinical trial, to evaluate impact of Triptolide wilfordii on T cell immune activation and inflammation biomarkers in HIV-infected immunological non-responders.
Timeline
- Start
- 2013-01
- Primary completion
- 2014-07
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triptolide | Traditional medicine (herbal / TCM) | 20 mg | Oral |
| Background | cART | Unknown | — | — |